Elagolix sodium,estradiol,norethindrone acetate; elagolix sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for elagolix sodium,estradiol,norethindrone acetate; elagolix sodium and what is the scope of patent protection?
Elagolix sodium,estradiol,norethindrone acetate; elagolix sodium
is the generic ingredient in one branded drug marketed by Abbvie Inc and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Elagolix sodium,estradiol,norethindrone acetate; elagolix sodium has thirty-seven patent family members in twenty-three countries.
One supplier is listed for this compound.
Summary for elagolix sodium,estradiol,norethindrone acetate; elagolix sodium
| International Patents: | 37 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for elagolix sodium,estradiol,norethindrone acetate; elagolix sodium
US Patents and Regulatory Information for elagolix sodium,estradiol,norethindrone acetate; elagolix sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for elagolix sodium,estradiol,norethindrone acetate; elagolix sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | See Plans and Pricing | See Plans and Pricing |
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | See Plans and Pricing | See Plans and Pricing |
| Abbvie Inc | ORIAHNN (COPACKAGED) | elagolix sodium,estradiol,norethindrone acetate; elagolix sodium | CAPSULE;ORAL | 213388-001 | May 29, 2020 | See Plans and Pricing | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for elagolix sodium,estradiol,norethindrone acetate; elagolix sodium
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| China | 100424078 | See Plans and Pricing | |
| Norway | 334897 | See Plans and Pricing | |
| Cyprus | 1108656 | See Plans and Pricing | |
| Japan | 5226760 | See Plans and Pricing | |
| World Intellectual Property Organization (WIPO) | 2005007165 | See Plans and Pricing | |
| New Zealand | 544747 | Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists | See Plans and Pricing |
| Japan | 2011088902 | PYRIMIDINE-2,4-DIONE DERIVATIVE AS GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONIST | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
